Free. Unsubscribe any time.
BIOCRYST PHARMACEUTICALS INC (BCRX)
BIOCRYST PHARMACEUTICALS INC filed 7 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 3 reporting owners, covering 8 transactions and 426,763 shares. None carries the SEC's AFF10B5ONE flag; all 7 name a plan in a footnote. No results print is on file in this window, so no interval is measured.
What stands out
- The most recent filing on file, dated 2026-05-15, came 58 days after the one before it (2026-03-18) and reports 3 transactions against 3 in the filing before it.
- The sales it reports total 62,500 shares, 87,500 fewer than the 150,000 in the filing before it.
- Its 7 filings on file run from 2025-11-17 to 2026-05-15, and state no plan adoption date.
Trades in BIOCRYST PHARMACEUTICALS INC 8
- SANDERS MACHELLE — 2025-11-13 · S · 9,600 shares
- Barnes Alane P — 2025-12-01 · S · 91,004 shares
- Barnes Alane P — 2025-12-02 · S · 50,906 shares
- Barnes Alane P — 2025-12-03 · S · 19,770 shares
- Barnes Alane P — 2025-12-15 · S · 21,210 shares
- Barnes Alane P — 2025-12-22 · S · 21,773 shares
- Barnes Alane P — 2026-03-16 · S · 150,000 shares
- Barnes Alane P — 2026-05-13 · S · 62,500 shares
Adoption dates in BIOCRYST PHARMACEUTICALS INC 0
Results prints in BIOCRYST PHARMACEUTICALS INC 0
Trades before a print in BIOCRYST PHARMACEUTICALS INC 0
Interval to BIOCRYST PHARMACEUTICALS INC’s next reported results date
How the interval and sources are counted →
- 0within 5 days
- 0within 10 days
- —shortest, days
- 8no later print
Sources: SEC EDGAR full-text search and the SEC submissions API.